肝细胞癌合并门静脉癌栓联合肝静脉栓塞介入转化缩小病肝体积后行吲哚菁绿辅助腹腔镜右半肝切除1例报告_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

高伟 ¹ , 吴昊钧 ² , 魏波 ³ ,  陈利平 ²

1. ;
2. ;
3. ;

Corresponding author：

陈利平, Email: schxclp@sina.com

Keywords：

门静脉癌栓; 肝静脉栓塞; 转化治疗; 吲哚菁绿; 腹腔镜右半肝切除

DOI：

10.7507/1007-9424.202207018

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 高伟, 吴昊钧, 魏波, 陈利平. 肝细胞癌合并门静脉癌栓联合肝静脉栓塞介入转化缩小病肝体积后行吲哚菁绿辅助腹腔镜右半肝切除1例报告. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(2): 221-223. doi: 10.7507/1007-9424.202207018 Copy

1.	Bruix J, Cheng AL, Meinhardt G, et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase Ⅲ studies. J Hepatol, 2017, 67(5): 999-1008.
2.	Chao Y, Chung YH, Han G, et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial. Int J Cancer, 2015, 136(6): 1458-1467.
3.	中国医师协会肝癌专业委员会. 肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2018年版). 临床肝胆病杂志, 2019, 35(4): 737-743.
4.	程树群, 吴孟超, 陈汉, 等. 肝癌门静脉癌栓分型的影像学意义. 中华普通外科杂志, 2004, 19(4): 200-201.
5.	Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74): 499-502.
6.	Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
7.	刘杰, 张成武, 洪德飞, 等. 腹腔镜前入路右半肝切除术治疗右肝巨大肿瘤. 中华普通外科杂志, 2017, 32(7): 581-584.
8.	关斌颖, 杨国际, 刘天锡. 吲哚菁绿荧光染色技术在腹腔镜精准肝切除术中的应用体会. 腹腔镜外科杂志, 2020, 25(12): 919-924.

1. Bruix J, Cheng AL, Meinhardt G, et al. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase Ⅲ studies. J Hepatol, 2017, 67(5): 999-1008.
2. Chao Y, Chung YH, Han G, et al. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial. Int J Cancer, 2015, 136(6): 1458-1467.
3. 中国医师协会肝癌专业委员会. 肝细胞癌合并门静脉癌栓多学科诊治中国专家共识(2018年版). 临床肝胆病杂志, 2019, 35(4): 737-743.
4. 程树群, 吴孟超, 陈汉, 等. 肝癌门静脉癌栓分型的影像学意义. 中华普通外科杂志, 2004, 19(4): 200-201.
5. Cheng SQ, Wu MC, Chen H, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepatogastroenterology, 2007, 54(74): 499-502.
6. Chebaro A, Buc E, Durin T, et al. Liver venous deprivation or associating liver partition and portal vein ligation for staged hepatectomy?: a retrospective multicentric study. Ann Surg, 2021, 274(5): 874-880.
7. 刘杰, 张成武, 洪德飞, 等. 腹腔镜前入路右半肝切除术治疗右肝巨大肿瘤. 中华普通外科杂志, 2017, 32(7): 581-584.
8. 关斌颖, 杨国际, 刘天锡. 吲哚菁绿荧光染色技术在腹腔镜精准肝切除术中的应用体会. 腹腔镜外科杂志, 2020, 25(12): 919-924.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

肝细胞癌合并门静脉癌栓联合肝静脉栓塞介入转化缩小病肝体积后行吲哚菁绿辅助腹腔镜右半肝切除1例报告

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content